Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Ganzin Unveils Gaze2AI™ Reference Design at AWE 2025: Redefining the Human-AI Interface with 3D Gaze Technology
-
Akeso's PD-1/CTLA-4 Bispecific Antibody Cadonilimab Approved for First-Line Treatment of Cervical Cancer in All-Comer Populations--Third Approved Indication for Cadonilimab
-
RECURRING NET INCOME OF R$ 4.9 BILLION IN 1Q25, UP 71.5% OVER 1Q24
-
CSE Bulletin: New Listing - Aleen Inc. (ALEN.U)
-
Sanatana Announces Closing of the Acquisition of the Gold Strike Two Project and the Concurrent Oversubscribed Private Placement
-
STEP Energy Services Ltd. Announces Annual General Meeting Voting Results and Appointment of Board Chair and Lead Director
-
Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering
-
Acerand Therapeutics Initiates First-in-Human Phase I Clinical Trial of ACE-232, a Novel CYP11A1 Inhibitor for Advanced Prostate Cancer
-
Foodie Box Love Unveils New BBQ Lovers Box: The Perfect Gift for Father's Day and Summer Grilling Season
-
Faraday X Holds Signing Ceremony with Initial B2B Partners, Reflecting Strong Support and Endorsement from U.S. Dealers and Multi-Channel Network Companies
-
Volition Announces Two Oral Presentations at Asian Meeting of Animal Medicine Specialties
-
BitMine Immersion Technologies, Inc. Announces $18 Million Public Offering and Uplisting to NYSE American
-
F4 Announces 2025 Exploration Program and Private Placement of up to $1.5 Million
-
AM Batteries Opens Doors to Customers, Expediting Electrode Sales for Next Generation Batteries
-
Babcock Injury Lawyers Announces Release of a Life-Changing Accident, Now Ranking in Amazon Legal Categories
-
Supreme Court of Bermuda Extends Interim Injunction Restraining ASA and Two of its Directors – Mary Joan Hoene and William Donovan – From Unauthorized Use of Company Resources
-
Innovent's IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) Receives Second NMPA Breakthrough Therapy Designation for Immuno-resistant Squamous Non-Small Cell Lung Cancer
-
Cathay General Bancorp Adopts New Share Repurchase Program
-
Ophir Metals Announces Option Grant
-
Greenberg Traurig Expands Labor & Employment Practice; Adds Shareholder Kelly Robreno Koster in Houston
-
Greenberg Traurig Adds Tech Transactions Shareholder Samuel Jo
-
Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Renal Cell Carcinoma
-
BWR Exploration Inc. Closes Tranche 2 of the Bridge Financing Pursuant to a Business Combination Transaction with Electro Metals and Mining Inc.
-
Alvotech has carried out a private placement of 7,500,000 SDRs and ordinary shares at a price of SEK 100.00 per SDR and ISK 1320.83 per ordinary share, raising gross proceeds of SEK 750 million
-
SQUARE ENIX Announces FINAL FANTASY TACTICS - The Ivalice Chronicles – Enhanced Version of Legendary RPG Coming to All Major Platforms on September 30
-
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma
-
Mustang Energy Corp. Enters Option Agreements with Thunderbird Resources Ltd.
-
American Trust Investment Services Serves as Exclusive Placement Agent for Fly-E Group Inc.'s Follow-On Offering
-
Alliance of M&A Advisors (AM&AA) and ShareVault Announce Strategic Partnership to Modernize Middle-Market Deal Execution
-
Kaldvík AS: Key information regarding potential subsequent offering
-
Kaldvík AS – Private placement successfully completed
-
Kelso Technologies Inc. Announces 2025 Annual General and Special Meeting Results
-
Violinist Cho-Liang Lin to Perform Tan Dun's Hero Concerto in China and Chamber Music at Montecito Music Festival
-
Digitate Advances Agentic AI Platform to Accelerate Enterprises Towards Autonomous, Ticketless IT and Business Operations
-
RGA Announces Coinsurance Transaction With Anshin Life
-
Palliser to Vote Against President Kobayashi and Other Directors at Forthcoming AGM to Break Keisei’s Destructive Cycle of Inaction and Management Entrenchment
-
Rakuten Medical's Anti-PD-L1 Antibody-IR700 Conjugate, RM-0256, Selected for AMED Funding
-
THIS LAS VEGAS BASED COMPANY IS SHAPING THE FUTURE OF CONCERTS - IKON PRESENTS
-
Belkin Unveils New Gaming Portfolio Featuring Power-Packed Charging Accessories and Gaming Essentials
-
Biocytogen and Nanjing Chia Tai Tianqing Announce IND Approval in China for Co-Developed Anti-IGF-1R Antibody NTB003 (BCG009)
-
Broadwind Announces Sale of Industrial Fabrication Operations in Manitowoc, Wisconsin
-
Skilled Immigrants are skipping the H-1B process and choosing faster paths to the Green Card
-
Australian Oilseeds Holdings Limited Announces Receipt of Nasdaq Notification Regarding Filing Delinquency
-
Volaris Reports May 2025 Traffic Results: Load Factor of 82%
-
ING Chauffeured Transportation Expands Fleet with Addition of Grech Minibuses and Volvo Coaches
-
Orlando Luxury Transportation Expands Fleet to Meet Rising Demand for Group Services
-
KBRA Releases Research – Non-QM Default Study: A Decade of Insights
-
James McGraw: A Life Freed by Storytelling
-
GIPR Announces Sale of Two Properties and Full Repayment of CMBS Loan
-
Foundation for Sarcoidosis Research Announces 2025 Global Virtual Sarcoidosis Summit – United for Progress: A New Chapter in Sarcoidosis
